IOL Chemicals and Pharmaceuticals Share Price

NSE: IOLCP

₹ 149.22

+₹2.23 (1.52%)

Last updated 24 Jul, 2026, 15:50 IST

₹143.66

1.52% up today

₹150.11

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 157.02% QoQ

Latest Earning

Net Profit TrendUp by 158.31% QoQ

Latest Earning

Revenue TrendUp by 6.08% QoQ

Stock Performance

OutperformingBeat Nifty by 10.27 % in last 1 month

Shareholding Pattern

PromoterPromoter increased stake by 8.35%

Shareholding Pattern

DIIDII increased stake by 11731.43%

Shareholding Pattern

FIIFII increased stake by 183.31%

IOL Chemicals and Pharmaceuticals Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹7,91,786+₹2,91,786 (+58.36%)

3 Year

₹9,45,028+₹4,45,028 (+89.01%)

5 Year

₹5,61,611+₹61,611 (+12.32%)

₹117.60₹176.38

Circuit Low

Circuit High

₹67.19₹179.60

52-Week Low

52-Week High

Circuit

₹117.60

₹176.38

52-week

₹67.19

₹179.60

Mkt Cap Cr

—

P/E

31.40

P/B

2.40

ROE

7.65%

D/E

0.08

ROCE

10.29%

Div. Yield

0.68%

EPS(TTM)

4.69

Turnover

1.22

EV/EBITDA

15.36

Net Margin

0.00%

Op. Margin

0.00%

ROA

5.32%

Quick Ratio

0.00

Curr. Ratio

2.20

Mkt Cap Cr

—

P/E

31.40

P/B

2.40

ROE

7.65%

D/E

0.08

ROCE

10.29%

Div. Yield

0.68%

EPS(TTM)

4.69

Turnover

1.22

EV/EBITDA

15.36

Net Margin

0.00%

Op. Margin

0.00%

ROA

5.32%

Quick Ratio

0.00

Curr. Ratio

2.20

Based on fundamentals, this stock's

Performance

Excellent

IOL Chemicals outperforming all market indices

Valuation

Overvalued

IOL Chemicals appears overvalued compared to its peers

Earnings

Excellent

IOL Chemicals revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,68,842.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.40	16.70%	97.21	0.12%	0.64	13.72

IOL Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹2,079.21	₹2,132.79	₹2,217.11	₹2,184.02
Other Income	₹22.41	₹30.07	₹25.61	₹32.04
Total Revenue	₹2,101.62	₹2,162.86	₹2,242.72	₹2,216.06
Total Expenses	₹1,963.66	₹1,981.21	₹2,054.07	₹1,977.28
Profit Before Tax	₹137.96	₹181.65	₹188.65	₹224.85
Tax	₹36.89	₹47.22	₹49.51	₹57.18
Profit After Tax	₹101.07	₹134.43	₹139.14	₹167.67
EPS - Basic	₹3.44	₹4.58	₹23.70	₹28.56
EPS - Diluted	₹3.44	₹4.58	₹23.70	₹28.56

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹137.96	₹181.65	₹188.65	₹224.85
Income before WC changes	₹217.81	₹241.47	₹233.06	₹257.97
Change in Assets	₹25.18	-₹71.66	₹41.30	-₹285.53
Change in Liabilities	-₹46.05	₹161.99	-₹104.99	₹183.19
Change in WC	-₹20.87	₹90.33	-₹63.69	-₹102.34
Cash flow from Operations	₹178.62	₹289.78	₹122.27	₹93.05
Cash flow from Investing	-₹154.18	-₹190.98	-₹120.00	-₹120.52
Cash flow from Financing	₹46.04	-₹92.50	-₹4.11	-₹1.64
Total Cash Flow	₹70.48	₹6.30	-₹1.84	-₹29.11
Cash (Start of the year)	₹7.69	₹1.39	₹3.23	₹32.34
Cash (End of the year)	₹78.17	₹7.69	₹1.39	₹3.23

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,230.73	₹1,124.63	₹1,101.74	₹881.48
Current Assets	₹1,151.34	₹1,119.77	₹920.39	₹1,080.82
Total Assets	₹2,382.07	₹2,244.40	₹2,022.13	₹1,962.30
Current Liabilities	₹609.91	₹560.00	₹456.26	₹513.40
Net Current Asset	₹541.43	₹559.77	₹464.13	₹567.42
Non-Current Liabilities	₹84.50	₹72.89	₹58.15	₹56.62
Equity Capital	₹1,687.66	₹1,611.51	₹1,507.72	₹1,392.28
Total Equity & Liabilities	₹2,382.07	₹2,244.40	₹2,022.13	₹1,962.30

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹2,079.21	₹2,132.79	₹2,217.11	₹2,184.02
Other Income	₹22.40	₹30.07	₹25.57	₹32.04
Total Revenue	₹2,101.61	₹2,162.86	₹2,242.68	₹2,216.06
Total Expenses	₹1,963.72	₹1,980.22	₹2,053.19	₹1,979.29
Profit Before Tax	₹137.89	₹182.64	₹189.49	₹222.84
Tax	₹36.89	₹47.22	₹49.51	₹57.18
Profit After Tax	₹101.00	₹135.42	₹139.98	₹165.66
EPS - Basic	₹3.44	₹4.61	₹23.84	₹28.22
EPS - Diluted	₹3.44	₹4.61	₹23.84	₹28.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹137.89	₹182.64	₹189.49	₹222.84
Income before WC changes	₹217.67	₹242.40	₹233.91	₹255.96
Change in Assets	₹25.18	-₹71.90	₹41.67	-₹285.53
Change in Liabilities	-₹45.85	₹161.98	-₹105.34	₹183.19
Change in WC	-₹20.67	₹90.08	-₹63.67	-₹102.34
Cash flow from Operations	₹178.68	₹290.46	₹123.14	₹91.04
Cash flow from Investing	-₹154.23	-₹191.39	-₹119.19	-₹120.62
Cash flow from Financing	₹46.04	-₹92.50	-₹4.11	-₹1.64
Total Cash Flow	₹70.49	₹6.57	-₹0.16	-₹31.22
Cash (Start of the year)	₹7.53	₹0.96	₹1.12	₹32.34
Cash (End of the year)	₹78.02	₹7.53	₹0.96	₹1.12

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,230.66	₹1,124.49	₹1,101.54	₹881.58
Current Assets	₹1,151.12	₹1,119.48	₹919.07	₹1,078.71
Total Assets	₹2,381.78	₹2,243.97	₹2,020.61	₹1,960.29
Current Liabilities	₹609.87	₹559.75	₹455.91	₹513.40
Net Current Asset	₹541.25	₹559.73	₹463.16	₹565.31
Non-Current Liabilities	₹84.50	₹72.89	₹58.15	₹56.62
Equity Capital	₹1,687.41	₹1,611.33	₹1,506.55	₹1,390.27
Total Equity & Liabilities	₹2,381.78	₹2,243.97	₹2,020.61	₹1,960.29

* All values are in INR Crore

Qty

Bid

9126

149.22

Ask

Qty

Bid Total: 9126

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

48.5

Neutral

ATR (14)

11.98

Neutral

STOCH(9,6)

5.07

Bullish

STOCH RSI (14)

Bullish

ADX(9)

35.19

Bearish

UO(9)

32.81

Neutral

ROC(12)

-10.94

Bearish

WillR(14)

-89.1

Bullish

Period

Simple value

Exponential vaue

150

151.33

10D

159.37

154.27

20D

155.01

152.08

50D

137.31

137.44

100D

109.6

120.51

About IOL Chemicals and Pharmaceuticals

ISIN

Sector Market Cap

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.

IOL Chemicals and Pharmaceuticals Financial Highlights

Revenue: IOL Chemicals and Pharmaceuticals reported revenue of ₹2,340.44 crore in FY26 vs ₹2,101.62 crore in FY25. It showed an increase of 11.36% on a yearly basis.
Operating Profit: IOL Chemicals and Pharmaceuticals reported an operating profit of ₹184.36 crore in FY26 vs ₹137.96 crore in FY25. It showed an increase of 33.63% on a year-on-year basis.
Net Profit: IOL Chemicals and Pharmaceuticals reported a net profit of ₹137.64 crore in FY26 vs ₹101.07 crore in FY25. It showed an increase of 36.18% on a yearly basis.

IOL Chemicals and Pharmaceuticals Quarterly Result Highlights

IOL Chemicals and Pharmaceuticals reported revenue of ₹621.29 crore in Mar 2026, compared with ₹585.68 crore in Dec 2025, representing an increase of 6.08% on a quarter-on-quarter (QoQ) basis.
IOL Chemicals and Pharmaceuticals reported an operating profit of ₹70.81 crore in Mar 2026, compared with ₹27.55 crore in Dec 2025, representing an increase of 157.02% on a quarter-on-quarter (QoQ) basis.
IOL Chemicals and Pharmaceuticals reported a profit of ₹53.16 crore in Mar 2026, compared with ₹20.58 crore in Dec 2025, reflecting an increase of 158.31% on a QoQ basis.
The earnings per share (EPS) of IOL Chemicals and Pharmaceuticals stood at ₹3.44 during Mar 2026.